Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
Axcelis Technologies Inc. (Nasdaq: ACLS) is a world-leading provider of equipment and services to the semiconductor manufacturing industry. For over 35 years, Axcelis has been a trusted partner for chipmakers globally, delivering cutting-edge solutions and expertise in the critical process of ion implantation. This process is essential for the fabrication of semiconductor chips used in everyday electronics such as smartphones, laptops, cameras, and more.
The company's suite of products includes advanced ion implantation systems, which form transistors that power electronic devices. Axcelis' Purion™ platform is renowned for its flexibility and advanced technology, catering to diverse needs from high current to high energy implants. The Purion Power Series™, particularly, addresses the growing demand in power device applications, including silicon carbide (SiC) technology, crucial for automotive, industrial, and energy applications.
Axcelis also offers comprehensive aftermarket services, including spare parts, equipment upgrades, maintenance, and customer training, ensuring maximum operational efficiency and longevity of its products. The company’s advanced technology center in Beverly, Mass., serves as a hub for innovation, collaborating with industry experts and customers to develop next-generation applications.
Financially robust, Axcelis continues to achieve record performance. In 2023, the company reported a 23% year-over-year growth, with revenues surpassing $1.1 billion. The strong market position is further evidenced by a $1.2 billion backlog at the year's end. Axcelis' strategic focus on the Asia Pacific region, which contributes significantly to its revenue, underscores its global outreach and market adaptability.
Recent achievements highlight Axcelis' leadership and innovation. The company showcased its latest technologies at SEMICON Korea 2024 and announced multiple shipments of its Purion Power Series™ to leading chipmakers worldwide. Axcelis also strengthened its board with new directors, bringing in valuable industry expertise.
As the semiconductor industry evolves, Axcelis remains committed to driving innovation and supporting its customers with state-of-the-art ion implantation solutions, ensuring a bright and technologically advanced future.
On March 8, 2021, Axcelis Technologies (Nasdaq: ACLS) announced the shipment of its first Purion H200 SiC Power Series™ implanter. This advanced equipment, designed for silicon carbide applications, was sent to a key power device manufacturer to support production ramp-up. The Purion H200 is the only single wafer high current implanter tailored for high dose implant applications. CEO Mary Puma highlighted the growing market for power devices, which represented over 17% of 2020 system sales, signaling significant revenue potential for Axcelis.
Axcelis Technologies (Nasdaq: ACLS) has announced its participation in two upcoming virtual investor conferences. The first is the Susquehanna Financial Group Tenth Annual Technology Conference on March 9, 2021, where management will engage in virtual one-on-ones and small group meetings. The second is the B. Riley Inaugural Clean Tech and Sustainability Virtual Investor Conference on March 10, 2021, featuring a fireside chat at 10:30 am EST with subsequent one-on-one meetings. A replay of the latter event will be available afterward.
Axcelis Technologies (Nasdaq: ACLS) announced the shipment of its second Purion XEmax high energy evaluation system to a leading foundry in the Asia Pacific region, aimed at CMOS image sensor manufacturing. This shipment, part of the first quarter, aligns with Axcelis' goal of reaching a $650M target business model amid increasing demand for high energy implants in the image sensor market. The Purion XEmax features enhanced capabilities, including patented Boost Technology™ for precise control, and builds on the established Purion XE platform for improved photodiode performance.
Axcelis Technologies (ACLS) reported strong financial results for Q4 and full year 2020. Q4 revenue reached $122.2 million, up from $110.4 million in Q3. Net income rose to $14.7 million or $0.43 per diluted share, benefiting from a $0.11 tax benefit. For the year, revenue surged to $474.6 million, a 38% increase from 2019, with net income of $50.0 million and diluted EPS of $1.46. Looking ahead, Q1 2021 revenue is expected between $118 million and $138 million.
Axcelis Technologies (Nasdaq: ACLS) has announced the shipment of its Purion H200™ high current implanter to a second leading power device manufacturer. This shipment aims to support production ramp for silicon power devices and reflects Axcelis's growth strategy in the power device market. The Purion H200 is notable for its versatility, precision, and productivity, catering to a wide energy range from 5keV to 200keV. This system is designed to meet the unique needs of foundry and power device manufacturers, enhancing their ability to develop advanced material modification applications.
Axcelis Technologies (Nasdaq: ACLS), a key player in ion implantation solutions for the semiconductor industry, will participate in B. Riley Securities' Vision Day on January 28, 2021. The event features a fireside chat with Kevin Brewer, executive vice president and CFO, and Doug Lawson, executive vice president of corporate marketing and strategy, scheduled for 3:30 p.m. EST. A webcast replay will be available post-event. Founded over 40 years ago, Axcelis is dedicated to enhancing semiconductor manufacturing processes. For more information, visit www.axcelis.com.
Axcelis Technologies (Nasdaq: ACLS) updated its fourth quarter 2020 financial guidance, expecting revenue of approximately $120 million, exceeding previous guidance of $110 million. Gross margin is projected at 43%, improved from 41%, with earnings per share rising to $0.32 from $0.21. The company also announced a $100 million share repurchase program for 2021, indicating strong confidence in operational prospects. Upcoming financial results will be disclosed on February 10, 2021, with a conference call scheduled for February 11, 2021.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the 23rd Annual Needham Virtual Growth Conference from January 11-15, 2021. Key executives including President and CEO Mary Puma, CFO Kevin Brewer, and EVP Doug Lawson will engage in a fireside chat on January 13 at 11:30 a.m. EST. The event will include one-on-one meetings and a live webcast accessible on their website. Axcelis, based in Beverly, Mass., specializes in ion implantation solutions for the semiconductor industry, boasting over 40 years of experience.
Axcelis Technologies (Nasdaq: ACLS) will participate in the 12th Annual CEO Investor Summit on December 16, 2020. Key executives, including Mary Puma, Kevin Brewer, and Doug Lawson, will engage in a virtual format with investors and analysts. This event allows for up to six meetings per company, and a pre-recorded company overview will be available for viewing 24 hours prior. Registration is required by December 10, 2020 to ensure participation in this exclusive event.
Axcelis Technologies (NASDAQ: ACLS) will participate in the virtual D.A. Davidson Semicap, Laser and Optical Conference on December 15, 2020. The management team will hold one-on-one meetings throughout the event. With over 40 years of experience, Axcelis supplies innovative ion implantation solutions critical to the semiconductor industry's manufacturing process.
FAQ
What is the current stock price of Axcelis Tech Ord (ACLS)?
What is the market cap of Axcelis Tech Ord (ACLS)?
What does Axcelis Technologies Inc. specialize in?
What are the key products of Axcelis Technologies?
How does Axcelis support its products post-sale?
Where is Axcelis Technologies headquartered?
What financial achievements did Axcelis report for 2023?
What is the significance of the Purion Power Series™?
How does Axcelis collaborate with the semiconductor industry?
What recent strategic moves has Axcelis made?
What upcoming events is Axcelis participating in?
What is the future outlook for Axcelis Technologies?
